26 Jun 2017 | 9:41 AM
 

Ind-Swift Laboratories Ltd. Share Price Live (BSE)
0

BSE Code: 532305 | NSE Symbol: INDSWFTLAB
36.60
-0.70
(-1.87 %)
23 Jun 2017 | 03:59 PM
Change company
  • Open (Rs)
    37.85
  • Prev. close (Rs.)
    37.30
  • High (Rs.)
    37.85
  • Low (Rs.)
    36.30
  • 52W H (Rs.)
    47.90
  • 52W L (Rs.)
    32.50
  • Volume (Rs.)
    48099
  • MCap (Rs in Cr.)
    163.67
No Data Available
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
-14.33
Operating Margin (%)
16.68
Gross Profit Margin (%)
3.71
Net Profit Margin (%)
-8.98
Total Debt/Equity
5.36
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
0.00

News

05 Sep 2012 - 09:38:00-Shares of drug maker Ind-Swift Laboratories plunged nearly 6 per cent on the Bombay Stock Exchange a...
17 May 2012 - 13:34:00-Ind-swift one of the leading pharmaceutical companies in India known for its drug research and d...
17 May 2012 - 10:41:00-Buoyed by the launching of Atorvastatin Tablets in UK shares of drug making company Ind-Swift Ltd ...
12 Apr 2012 - 11:30:00-Shares of Ind-Swift laboratories soared nearly 6 per cent after the news that company got USFDA appr...

Announcements

02-Jun-2017
Ind-Swift Laboratori - Financial Results For 31St March 2017
23-May-2017
Ind-Swift Laboratori - Outcome of Board Meeting
11-May-2017
Ind-Swift Laboratori - Board Meeting On 23Rd May 2017
11-May-2017
Ind-Swift Laboratori - Closure of Trading Window
29-Apr-2017
Ind-Swift Laboratori - CERTIFICATE UNDER REGULATION 40 (9) & (10) OF THE SEBI (LODR) REGULATIONS 2015

Religare Research

23 Jun 2017 | 06:00 PM
This week, we haven’t recommended fresh position, keeping in mind overbought market condition and nu...
23 Jun 2017 | 06:00 PM
Nifty consolidated for yet another week and settled almost flat in the end, tracking mixed cues.
23 Jun 2017 | 11:34 AM
Agri Fundamental and Technical report
23 Jun 2017 | 09:57 AM
The Indian rupee fell to a more-than-three-week low against the dollar, weighed down by last-minute ...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
No Data Available

Shareholding Pattern

       
Promotors55.49%
Mutual Funds/UTI0.00%
FI/Banks0.00%
Insurance0.00%
FII2.27%
Government0.00%
Others8.25%

Peer Group

Company Intraday Graph
 Neuland Laboratories Ltd.
1,387.95(-0.10)
3578
 Kovai Medical Center and Hospital Ltd.
1,215.05(-1.20)
11816
 Merck Ltd.
1,085.00(-1.44)
3302
 AstraZeneca Pharma India Ltd.
915.00(-0.28)
3274

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Ind-Swift Laboratories Ltd.-3.050.950.95
NIFTY(S&P CNX)188.80488.651,589.20
BSE SENSEX772.961,806.055,097.51
BSE 500314.24752.842,426.41

Corporate Details

Key Personal
G Munjal
Non Executive Director
G Munjal
Promoter Non-Exe.Director
Himanshu Jain
Joint Managing Director
Key Address
Registered Office
SCO 850 Shivalik Enclave NAC Manimajra,Chandigarh,Chandigarh

Tel:0172-5061850 2730920, Fax:0172-2730504 2736294

investor@indswiftlabs.com
http://www.indswiftlabs.com
Registrar Office
Alankit Assignment Ltd.
Add. :1E/13 Alankit Heights Jhandewalan Extension

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Ind-Swift Laboratories Ltd. that will help you decide whether to buy, sell or hold Ind-Swift Laboratories Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Ind-Swift Laboratories Ltd.